News Image

Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI® Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication Use

Provided By GlobeNewswire

Last update: Sep 17, 2025

MENLO PARK, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today announced the results as published in the European Journal of Ophthalmology of a systematic review and meta-analysis of the clinical effectiveness, safety, humanistic and economic impact of the OMNI Surgical System (OMNI).

Read more at globenewswire.com

SIGHT SCIENCES INC

NASDAQ:SGHT (10/13/2025, 8:00:02 PM)

After market: 3.26 0 (0%)

3.26

+0.06 (+1.87%)



Find more stocks in the Stock Screener

Follow ChartMill for more